CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Yam, Clinton, Hung, Mien-Chie, Hortobagyi, Gabriel N.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2018
Teme:
Editorial
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6188130/
https://ncbi.nlm.nih.gov/pubmed/30344934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26134
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items